Assembly Biosciences, Inc. reported progress in its clinical development of antiviral candidates, with data from multiple programs expected in 2025. Specifically, interim Phase 1b data for long-acting ...

TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) today announced it will release its second quarter 2025 financial results after the stock market ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Today at Adobe‘s annual digital innovation ...

BOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that researchers will ...

Werewolf Therapeutics updates on clinical trials, financial results, and plans for proprietary T cell engager development amidst strong cash position. Werewolf Therapeutics, Inc. announced significant ...

POTOMAC, MD / ACCESS Newswire / August 27, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced that Ascendiant Capital Markets has issued a coverage report entitled: "Reports Q1 results. We ...

Capital One Financial Corp (NYSE:COF), currently valued at $77.8 billion and trading near its 52-week high of $207.24, provided an update today on its ongoing merger with Discover Financial Services ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...